| Substantial neutralization escape by SARS-CoV-2 Omicron variants BQ. 1.1 and XBB. 1 J Miller, NP Hachmann, AY Collier, N Lasrado, CR Mazurek, RC Patio, ... New England Journal of Medicine 388 (7), 662-664, 2023 | 168 | 2023 |
| An overview of the immune mechanisms of viral myocarditis N Lasrado, J Reddy Reviews in medical virology 30 (6), 1-14, 2020 | 116 | 2020 |
| Neutralization escape by SARS-CoV-2 Omicron subvariant BA. 2.86 N Lasrado, YC Ai-ris, NP Hachmann, J Miller, M Rowe, ED Schonberg, ... Vaccine 41 (47), 6904-6909, 2023 | 57 | 2023 |
| IL-10 as a Th2 Cytokine: Differences Between Mice and Humans MT Rasquinha, M Sur, N Lasrado, J Reddy The Journal of Immunology 207 (9), 2205-2215, 2021 | 46 | 2021 |
| Waning immunity and IgG4 responses following bivalent mRNA boosting N Lasrado, AY Collier, J Miller, NP Hachmann, J Liu, T Anand, ... Science Advances 10 (8), eadj9945, 2024 | 42* | 2024 |
| Cardiac Myosin-Specific Autoimmune T Cells Contribute to Immune Checkpoint Inhibitor-Associated Myocarditis T Won, HM Kalinoski, MK Wood, DM Hughes, CM Jaime, M Talor, ... Cell Reports 41 (6), 111611, 2022 | 42 | 2022 |
| Mechanisms of sex hormones in autoimmunity: focus on EAE N Lasrado, T Jia, C Massilamany, R Franco, Z Illes, J Reddy Biology of sex Differences 11, 1-14, 2020 | 33 | 2020 |
| Viral myocarditis involves the generation of autoreactive T cells with multiple antigen specificities that localize in lymphoid and non-lymphoid organs in the mouse model of … RH Basavalingappa, R Arumugam, N Lasrado, B Yalaka, C Massilamany, ... Molecular immunology 124, 218-228, 2020 | 28 | 2020 |
| SARS-CoV-2 hybrid immunity: the best of both worlds N Lasrado, DH Barouch The Journal of Infectious Diseases 228 (10), 1311-1313, 2023 | 23 | 2023 |
| Triggers of inflammatory heart disease N Lasrado, B Yalaka, J Reddy Frontiers in Cell and Developmental Biology 8, 192, 2020 | 21 | 2020 |
| Attenuated strain of CVB3 with a mutation in the CAR-interacting region protects against both myocarditis and pancreatitis N Lasrado, A Gangaplara, C Massilamany, R Arumugam, A Shelbourn, ... Scientific Reports 11 (11), 2021 | 19 | 2021 |
| Identification of immunogenic epitopes that permit the detection of antigen-specific T cell responses in multiple serotypes of group B coxsackievirus infections N Lasrado, A Gangaplara, R Arumugam, C Massilamany, S Pokal, Y Zhou, ... Viruses 12 (3), 347, 2020 | 18 | 2020 |
| Dissecting the cellular landscape and transcriptome network in viral myocarditis by single-cell RNA sequencing N Lasrado, N Borcherding, R Arumugam, TK Starr, J Reddy iScience 25 (3), 2022 | 15 | 2022 |
| Vaccines against Group B Coxsackieviruses and Their Importance K Mone, N Lasrado, M Sur, J Reddy | 8 | 2023 |
| A Monovalent Mt10-CVB3 Vaccine Prevents CVB4-Accelerated Type 1 Diabetes in NOD Mice MT Rasquinha, N Lasrado, M Sur, K Mone, H Qiu, JJ Reithoven, ... Vaccines 11 (76), 2022 | 7 | 2022 |
| PhIP-Seq reveals autoantibodies for ubiquitously expressed antigens in viral myocarditis MT Rasquinha, N Lasrado, E Petro-Turnquist, E Weaver, T Venkataraman, ... Biology 11 (7), 1055, 2022 | 7 | 2022 |
| Mt10-CVB3 Vaccine Virus Protects against CVB4 Infection by Inducing Cross-Reactive, Antigen-Specific Immune Responses N Lasrado, R Arumugam, MT Rasquinha, M Sur, D Steffen, J Reddy Microorganisms 9 (11), 2323, 2021 | 7 | 2021 |
| Neutralization of SARS-CoV-2 omicron subvariant BA. 2.87. 1 N Lasrado, A Rössler, M Rowe, YC Ai-ris, DH Barouch Vaccine 42 (9), 2117-2121, 2024 | 5 | 2024 |
| Mpox infection protects against re-challenge in rhesus macaques M Aid, M Sciacca, K McMahan, D Hope, J Liu, C Jacob-Dolan, O Powers, ... Cell 186 (21), 4652-4661. e13, 2023 | 4 | 2023 |
| Evidence for anti-viral effects of complete Freund’s adjuvant in the mouse model of Enterovirus infection A Gangaplara, C Massilamany, N Lasrado, D Steffen, J Reddy Vaccines 8 (3), 364, 2020 | 4 | 2020 |
